Effector Therapeutics Inc Free Cash Flow Generation Index

Latest as of June 2020: 1.00x

Effector Therapeutics Inc free cash flow generation index. Effector Therapeutics Inc (EFTR) has a Free Cash Flow Generation Index of 1.00x as of June 2020. Free cash flow of $11.98 Million represents 1% of operating cash flow ($11.98 Million).

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$11.98 Million
USD

Operating Cash Flow

$11.98 Million
USD

Capital Expenditures

$0.00
USD

Free Cash Flow Generation Index of Effector Therapeutics Inc (2020–2020)

Free cash flow generation index of Effector Therapeutics Inc from 2020 to 2020. Historical FCF Generation Index trend for Effector Therapeutics Inc across 1 annual periods. See financial agility of Effector Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.

Effector Therapeutics Inc Free Cash Flow Generation Index by Year (2020–2020)

Effector Therapeutics Inc free cash flow generation index by year from 2020 to 2020. Year-by-year Free Cash Flow Generation Index for Effector Therapeutics Inc. For the full cash flow conversion analysis, see EFTR cash generation efficiency.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2020 0.99x $13.68 Million $13.84 Million $154.00K —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).